Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00804479 · ClinicalTrials.gov registry record
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
A clinical trial, sponsored by University of Rochester.
- Terminated
- Registry status
- 222
- Enrollment target
NCT00804479: Clinical Trial study, sponsored by University of Rochester.
NCT00804479 is a clinical trial that was terminated before completion, run by University of Rochester. The registered enrollment target is 222 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00804479 was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- 222 participants
- Enrollment target
Study Summary
To determine the long-term consequences (8 years) of initiating patients with Parkinson's disease on either pramipexole or levodopa. We hypothesize that patients initiating therapy with pramipexole compared with levodopa will demonstrate less self-reported disability as measured by the Modified Schwab and England (S/E) scale 8 years after randomization.
Interventions
- OTHER No intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2002-01 |
| Est. Completion | 2004-03 |
Why NCT00804479 stopped before completion
NCT00804479 is an observational study that tracks outcomes without assigning an intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No intervention. is the first listed.
NCT00804479 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00804479 about?
NCT00804479 is a clinical study titled "The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)". To determine the long-term consequences (8 years) of initiating patients with Parkinson's disease on either pramipexole or levodopa. We hypothesize that patients initiating therapy with pramipexole compared with levodopa will demonstrate less self-reported disability as measured by the Modified Schw...
What is the current status of trial NCT00804479?
This trial is currently terminated. The enrollment target is 222 participants. The study started on 2002-01. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00804479?
The interventions under investigation include: No intervention. (OTHER).
Who is sponsoring clinical trial NCT00804479?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia